Michael J. Ackerman MD, PhDWindland Smith Rice Cardiovascular Genomics Research Professor; Professor of Medicine, Pediatrics, and Pharmacology; Director of the Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota
Michael J. Ackerman, MD, PhD is the Windland Smith Rice Cardiovascular Genomics Research Professor and Professor of Medicine, Pediatrics, and Pharmacology at the Mayo Clinic in Rochester, Minnesota. Dr. Ackerman was born and raised in Iowa. He graduated valedictorian from Sheldon High School in 1984, and in 1988, he graduated summa cum laude from Luther College in Decorah, Iowa majoring in chemistry and mathematics. He received his MD and PhD degrees from the Mayo Clinic Alix School of Medicine and the Mayo Clinic Graduate School of Biomedical Sciences in 1995 and completed residency (pediatrics) and fellowship (pediatric cardiology) training in the Mayo Clinic Graduate School of Medicine in 2000.
He has been a faculty member of Mayo Clinic since July 2000 and has served as President of the Sudden Arrhythmia Death Syndromes (SADS) Foundation since 2006. In 2018, he received the Heart Rhythm Society’s Distinguished Scientist Award, and in 2021, he was inducted into the Association of American Physicians. He was named Mayo Clinic’s Distinguished Clinician in 2015 and its Distinguished Investigator in 2021.
As Director of Mayo Clinic’s Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory, Dr. Michael Ackerman strives to fulfill the two-fold objective of medical education and biomedical research as stated by Dr. Charles H. Mayo: “to heal the sick and to advance the science.”
DisclosuresDr. Ackerman reports the following:
- Consultant for: Boston Scientific, Gilead Sciences, Medtronic, and St. Jude Medical
- Royalties from: Transgenomic for FAMILION-LQTS and FAMILION-CPVT genetic tests
Recent Contributions to PracticeUpdate:
- Arrhythmia Variants in a Multi-Center Cohort
- Effectiveness of ICDs to Reduce Mortality in Patients With Long QT Syndrome
- Interplay Among Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome
- The Molecular Autopsy From Down Under
- Sudden Cardiac Death Among Children and Young Adults
- Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in EMR
- MY APPROACH to Treatment of the Congenital Long QT Syndromes